Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Mod GRF 1-29 vs. CJC-1295 with DAC: A Head-to-Head Comparison

To make this as clear as possible, our team put together a quick comparison. It’s not about which one is "better"—that's the wrong question. It's about which tool is appropriate for a given experiment. We’ve seen countless research projects get derailed becaus

This comparison does not assign a generated winner or score.

  • To make this as clear as possible, our team put together a quick comparison. It’s not about which one is "better"—that's the wrong question. It's about which tool is appropriate for a given experiment. We’ve seen countless research projects get derailed because the wrong tool was chosen at the outset.
  • Active Half-Life
  • Approximately 30 minutes
  • Up to 8 days
  • GH Release Pattern
  • Sharp, high-amplitude pulse
  • Slow, sustained elevation ("GH bleed")
  • Mechanism
  • Mimics natural, pulsatile GHRH signaling
  • Creates a continuous, low-level signal
  • Administration
  • Requires more frequent administration for studies needing multiple pulses
  • Infrequent administration (e.g., weekly)
  • Primary Research Use
  • Studying effects of natural GH pulses (e.g., sleep, recovery, anti-aging models)
  • Studying effects of long-term, stable GH elevation
  • Receptor Sensitivity
  • Preserves pituitary receptor sensitivity
  • Potential for receptor downregulation over time
  • Common Name
  • Mod GRF 1-29, Modified GRF (1-29)
  • CJC-1295 DAC, Long-acting CJC
  • As you can see, these are two fundamentally different compounds designed for starkly different research protocols. Choosing Mod GRF 1-29 means prioritizing a release pattern that mirrors the body's own sophisticated rhythm.
More references

Related material